Circulating Orexin-A Levels in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Systematic Review and Meta-Analysis. [PDF]
CureusAlmahwzi S +8 more
europepmc +1 more source
Awakening Recovery: Enhancing Orexinergic Tone After Acute CNS Damage. [PDF]
Pharmaceuticals (Basel)Otero-López P +3 more
europepmc +1 more source
The therapeutic pipeline in migraine: What does the future hold? [PDF]
NeurotherapeuticsGamal-Eltrabily M +3 more
europepmc +1 more source
Investigation of a simple suspension method for orexin receptor antagonist tablets. [PDF]
J Pharm Health Care SciHada K +6 more
europepmc +1 more source
Neuropsychiatric signs and symptoms of Alzheimer\u27s disease: New treatment paradigms [PDF]
, 2017 et al,, Musiek, Erik
core +1 more source
Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. [PDF]
Front PharmacolMa D +8 more
europepmc +1 more source
Targeting the Orexin System in the Pharmacological Management of Insomnia and Other Diseases: Suvorexant, Lemborexant, Daridorexant, and Novel Experimental Agents. [PDF]
Int J Mol SciŻełabowski K +11 more
europepmc +1 more source
Increased Orexin by High Concentration of Sevoflurane Enhances the Suprahyoid Muscle Activity Involves in Gasping-Like Respiration of Mice. [PDF]
FASEB BioadvIrukayama-Tomobe Y +14 more
europepmc +1 more source
Lemborexant overdose presenting with mild sedation despite high plasma levels: A case report. [PDF]
Toxicol RepSuzuki M +4 more
europepmc +1 more source
Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1. [PDF]
Ann Med Surg (Lond)Arif Z +4 more
europepmc +1 more source